TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says April 26, 1996
TCL Archive Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around December 7, 1979
TCL Archive National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program. July 11, 2008